Device developer Merxin has announced the availability of its MRX001 “off the shelf” multidose dry powder inhaler.
According to an announcement on the website of Merxin sister company Aedestra, the blister-based DPI is designed for developers of generic combination products planning to submit a 505(j) application.
Read the Aedestra announcement.
